POM

POMDOCTOR Ltd

Nasdaq· Retail-Miscellaneous Retail· Inc. E9· CIK 0001877971 Consumer & Retail

$1.39 +0.26 (+23.01%)

Oct 27 4:00 PM ET · prev $1.13

Market cap

$3.3M

Nano cap

1 year

−98.4%

from $86.76 · Oct 28

30 days

+52.7%

from $0.9100

52-week range

$0.5310–109.62

−99% from high · low Oct 19

Avg volume 20D

4.07M

Oct 21 spike 48.81M

Short interest

22.5K

≈0.8% of shares · −13.3%

Days to cover

1.0

at average volume

Reddit crowd

50°

Neutral · 4 mentions this week

Filing reports

analyzed by SecBot

SecBot read BEARISH 8 reports · 90 days

Balance 1 bearish · 0 bullish · 1 mixed · 6 neutral oldest → newest, height = score

Avg score

·High conf. 4/8

Strongest BEARISH POMDOCTOR received a Nasdaq staff delisting determination on October 6, 2026, because its ADS bid price…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Aug 14 Short interest jumps 36.4% to 26.0K
X Aug 31 Short interest falls 25.2% to 19.4K
X Sep 30 Short interest jumps 42.1% to 26.0K
R Oct 9 POMDOCTOR received a Nasdaq staff delisting determination on October…
E Oct 22 Trading halt: Halt Resumed: POM — trading resumed after LUDP (Volatility…
E Oct 22 Trading halt: Trading Halt: POM — LUDP (Volatility Trading Pause)

Signal stack

Where each data set points today.

Short sellersSTEADY

Short interest −13.3% to 22.5K shares. 1.0 days to cover, ≈0.8% of shares.
TrendUPTREND

49% above its 50-day average.
SocialQUIET

Crowd 50° (neutral) this week from 4 mentions: 0 bullish, 0 bearish. No setup call.

Who's buying

13F

Top holder	Shares	Value
CITADEL ADVISORS LLC	21,273	$30.8K
UBS Group AG	3,463	$5.0K
Arax Advisory Partners	722	$1.0K
Steward Partners Investment Advisory, LLC	111	$161.00
RHUMBLINE ADVISERS	41	$60.00

Quarterly 13F filings are due 45 days after each quarter ends.

Reddit mentions per day, 14 days

Crowd this week 50° Neutral 0 bullish · 0 bearish

Mentions, 7 days 4 4 in posts · 0 in comments

Earnings setup

Estimates

Period	EPS est.	Range	30D rev.	Revenue
Current Q	—	—	—	$0.00
Next Q	—	—	—	$0.00
Current FY	—	—	—	$0.00
Next FY	—	—	—	$0.00

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 22, 2026 Trading halt

Halt Resumed: POM — trading resumed after LUDP (Volatility Trading Pause)

Halted 2026-10-22T15:18:28.000Z | Resumed 2026-10-22T15:23:28.000Z

Oct 19, 2026 SEC

POMDOCTOR is terminating its ADR program and converting to a direct listing of Class A ordinary shares on Nasdaq…

6-K — Impact 4/10

Oct 9, 2026 SEC

POMDOCTOR received a Nasdaq staff delisting determination on October 6, 2026, because its ADS bid price closed below…

6-K — Impact 8/10

Sep 30, 2026 SEC

POMDOCTOR Ltd filed a 6-K with a press release providing a strategic update on its AI-enabled chronic disease…

6-K — Impact 3/10

Short side

FINRA· Oct 15, 2026

22,500

shares short

-13.3%

vs prior settlement

1.0

days to cover

≈0.8%

of shares outstanding

Trading halts

Oct 22, 2026	Volatility Pause	Resumed
Oct 22, 2026	Volatility Pause	Resumed
Oct 22, 2026	Volatility Pause	Resumed
Oct 22, 2026	Volatility Pause	Resumed
Oct 22, 2026	Volatility Pause	Resumed